Routine Assessment of Patient Index Data 3 score (RAPID3) correlates well with Bath Ankylosing Spondylitis Disease Activity index (BASDAI) in the assessment of disease activity and monitoring progression of axial spondyloarthritis

Danve, Abhijeet; Reddy, Anusha; Vakil-Gilani, Kiana; Garg, Neha; Dinno, Alexis; Deodhar, Atul

doi:10.1007/s10067-014-2827-4

Cited by 34 publications

(24 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…These indirect comparisons show that XLH adults have a lower QoL than the general population (26,27) and their QoL is close to that of patients with chronic diseases ( (29,32). We compared the XLH adults to ax-SpA patients because structural damages are comparable in both diseases including ossifications and enthesopathies ( Table 2).…”

Section: Comparison With General Population and Other Chronic Rheumatmentioning

confidence: 83%

See 1 more Smart Citation

Impaired quality of life in adults with X-linked hypophosphatemia and skeletal symptoms

Che

Roux

Etcheto

et al. 2016

European Journal of Endocrinology

131

139

View full text Add to dashboard Cite

Objective: Adults with X-linked hypophosphatemia (XLH) may suffer from skeletal symptoms leading to functional disability. No data on their quality of life (QoL) have been reported so far. Our objectives were to evaluate the QoL and its determinants in XLH adults. Patients and methods: We conducted a prospective study in XLH adults, who consulted for musculoskeletal symptoms between 2013 and 2014. We assessed their QoL using HAQ, RAPID3 and SF36, and analysed the variables associated with low QoL. We compared their QoL to that of patients affected with axial spondyloarthritis (ax-SpA) (paired on age and gender), a rheumatologic disorder with a known low QoL. Results: Fifty-two XLH adults (37 women (71.1%); mean age 41.8G13.3 years) were included; 44 (84.6%) patients had an altered QoL. Increased age and presence of structural lesions were significantly associated with worse QoL (HAQ, RAPID3) (P!0.05). Presence of enthesopathies was significantly associated with worse RAPID3 (ORZ4.45 (1.09-18.29), PZ0.038). Treatment with phosphate supplements and vitamin D in XLH adults were significantly associated with a better SF36-mental component score (ORZ0.14 (0.03-0.57), PZ0.007 and ORZ0.26 (0.07-0.98), PZ0.047 respectively). QoL was significantly worse in XLH than in ax-SpA adults (VAS pain, SF36-PCS, RAPID3) (P!0.05). Conclusion: Our study showed i) QoL of XLH adults is altered and significantly worse than that of ax-SpA patients (VAS pain, SF36-PCS and RAPID3), ii) structural lesions and especially enthesopathies are associated with a worse QoL and iii) treatment using phosphate supplements and/or vitamin D is associated with a better mental health score.

show abstract

Section: Comparison With General Population and Other Chronic Rheumatmentioning

confidence: 83%

“…These patients gave their oral consent for the participation in this study. The HAQ, RAPID3 and SF36 scores have been validated in ax-SpA (25,26).…”

Section: Axial Spondyloarthritis Control Groupmentioning

confidence: 99%

Impaired quality of life in adults with X-linked hypophosphatemia and skeletal symptoms

Che

Roux

Etcheto

et al. 2016

European Journal of Endocrinology

131

139

View full text Add to dashboard Cite

show abstract

“…The MDHAQ/RAPID3 was developed initially to assess patients with RA, but has been reported to be valuable in monitoring status and status changes over time in all rheumatic diseases in which it has been studied , including OA , SLE , AS , PsA , gout , PMR , and vasculitis . These observations illustrate the potential value of using the same questionnaire in patients with different rheumatic diseases.…”

Section: Discussionmentioning

confidence: 99%

Disease Burden in Osteoarthritis Is Similar to That of Rheumatoid Arthritis at Initial Rheumatology Visit and Significantly Greater Six Months Later

Chua

Jamal

Riad

et al. 2019

Arthritis & Rheumatology

View full text Add to dashboard Cite

Objective To analyze disease burden in osteoarthritis (OA) according to Multidimensional Health Assessment Questionnaire (MDHAQ)/Routine Assessment of Patient Index Data 3 (RAPID3) scores at the initial visit and the 6‐month follow‐up visit, compared with rheumatoid arthritis (RA) as a benchmark for high disease burden. Methods All patients with all diagnoses at the Rush University Medical Center Division of Rheumatology complete a paper MDHAQ at all visits, saved as a PDF in the electronic health record. MDHAQ 0–10 scores for physical function, pain, and patient global assessment (compiled into RAPID3 0–30 scores) and additional scales at the initial and 6‐month follow‐up visits, for new OA and RA patients seen from 2011 to 2017, were compared. OA and RA patients were classified as self‐referred or physician‐referred, and RA patients were classified as disease‐modifying antirheumatic drug (DMARD)–naive or having prior‐DMARD treatment. Patient groups were compared using t‐tests and analysis of variance, adjusted for age, disease duration, body mass index (BMI), education, and ethnicity. Results Compared with RA patients, OA patients had higher age, BMI, and disease duration. At initial visit, the mean RAPID3 did not differ significantly in OA versus DMARD‐naive RA patients, whether self‐ or physician‐referred (range 14.8–16.4 [P = 0.38]), or in all OA patients versus DMARD‐naive RA patients versus prior‐DMARD RA patients (15.0, 15.7, and 15.8, respectively [P = 0.49]). After 6 months, RAPID3 was improved to 13.3, 10.3, and 10.8, respectively, which represented substantially greater improvement in RA patients than OA patients (P < 0.001). Similar results were seen for most self‐reported measures and in adjusted analyses. Conclusion MDHAQ/RAPID3 scores are similar in OA and RA patients at the initial visit, but higher in OA patients than in RA patients 6 months later, reflecting superior RA treatments. The same MDHAQ/RAPID3 allows comparisons of disease burdens in different diseases.

show abstract

“…[17,18] The mean BASDAI score of the participants in our study was 4.34, and if we generalize, it is understood that their disease levels were active. As a result of BASFI, which we used to understand how difficult or easy the activities individuals meet or will meet during their daily lives are, it was found that the individuals did not experience restrictions in daily activities.…”

Section: Discussionmentioning

confidence: 96%

Determining the relationship of kinesiophobia with respiratory functions and functional capacity in ankylosing spondylitis

Angın

2017

Medicine

View full text Add to dashboard Cite

Ankylosing spondylitis (AS) is a common inflammatory rheumatic disease that affects the axial skeleton, causes inflammatory lower back pain, and structural and functional disorders, which affect quality of life negatively.The purpose of this study is to investigate the effects of kinesiophobia in AS on pulmonary function tests (PFTs) and functional performance.Thirty-one individuals with AS (n = 19 male, n = 12 female) who were suitable on the basis of the Modified New York (MNY) criteria were included in the study. The participants were given the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), the Bath Ankylosing Spondylitis Functional Index (BASFI), the Bath Ankylosing Spondylitis Metrology Index (BASMI), in addition to the Tampa Scale for Kinesiophobia (TKS), PFTs, respiratory muscle strength, pain evaluation, and 6-minute walking test (6MWT).The mean values were found as the following: TKS, 41.65 ± 7.59; pain visual analog scale (VAS) score, 6.23 ± 2.86; forced vital capacity (%) (FVC), 75.35% ± 17.92%; forced expiratory volume in first second (%) (FEV1), 73.45% ± 17.20%; FEV1/FVC (%), 75.58% ± 15.99%; peak expiratory flow (%) (PEF), 54,90% ± 20.21%; forced expiratory flow at 25% to 75% (FEF25–75), 77.71% ± 27.05%; maximal inspiratory pressure (MIP), 62.06 ± 31.68; maximal expiratory pressure (MEP), 95.94 ± 36.60; 6MWT, 445.88 ± 99.48. The scores obtained in TKS were found related to the values of FVC (%), FEV1 (%), chest expansion, BASFI, modified Schober test, lumbar lateral flexion, cervical rotation, and total BASMI score (r = −0.43, −0.36, −0.41, 0.42, −0.49, −0.56, −0.52, 0.56, respectively; P < .05).Kinesiophobia is a condition that may arise in individuals with AS, which has negative effects. Physiotherapists have a responsibility to eliminate kinesiophobia beliefs and prefer therapy method in line with this responsibility.

show abstract

Routine Assessment of Patient Index Data 3 score (RAPID3) correlates well with Bath Ankylosing Spondylitis Disease Activity index (BASDAI) in the assessment of disease activity and monitoring progression of axial spondyloarthritis

Cited by 34 publications

References 18 publications

Impaired quality of life in adults with X-linked hypophosphatemia and skeletal symptoms

Impaired quality of life in adults with X-linked hypophosphatemia and skeletal symptoms

Disease Burden in Osteoarthritis Is Similar to That of Rheumatoid Arthritis at Initial Rheumatology Visit and Significantly Greater Six Months Later

Determining the relationship of kinesiophobia with respiratory functions and functional capacity in ankylosing spondylitis

Contact Info

Product

Resources

About